Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

TBXU vs CURE overlap: 40% of top holdings shared

Bottom line

How much do TBXU and CURE overlap?

40% of their top holdings overlap by weight. 8 securities appear in both funds' top 25, making up 84.1% of TBXU's assets and 42.4% of CURE's. They share a meaningful core but differ in the rest of the portfolio.

CURE holds far more positions (67 vs 10), so it is broader beyond the top names.

Updated Nov 22, 2026

Overlap at a glance

TBXUCURE
Weight overlap (top 25)40%
Shared holdings8
Weight in shared holdings84.1%42.4%
Total positions1067
Expense ratio0.98%0.94%
Holdings as ofJul 31, 2026Jul 31, 2026

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)

Holdings TBXU and CURE have in common

Holding% of TBXU% of CUREOverlap
Goldman Financial29.36%7.51%7.51%
Dreyfus21.64%18.79%18.79%
Amgen Inc AMGN7.95%2.38%2.38%
Vertex Pharmaceuticals Inc VRTX7.84%1.39%1.39%
Gilead Sciences Inc GILD7.58%1.85%1.85%
Goldman Sachs Liq Es Fd A6.23%8.19%6.23%
N/a2.83%1.12%1.12%
N/a0.62%1.12%0.62%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in TBXU

  1. Regeneron Pharmaceuticals Inc — 9.09%
  2. Argenx Se - Adr — 6.98%

Only in CURE

  1. Eli Lilly & Company — 10.41%
  2. Johnson & Johnson — 7.07%
  3. Abbvie Inc — 5.08%
  4. Unitedhealth Group Inc — 4.31%
  5. Merck & Company Inc — 3.68%
  6. Thermo Fisher Scientific Inc — 2.45%
  7. Abbott Laboratories — 2.11%
  8. Pfizer Inc — 1.63%
  9. Bristol-myers Squibb Co — 1.53%
  10. Cvs Health Corp — 1.53%
  11. Intuitive Surgical Inc — 1.43%
  12. Danaher Corp — 1.41%
  13. Stryker Corp — 1.29%
  14. Medtronic Plc — 1.26%
  15. Mckesson Corp — 1.18%

Asset mix

Asset typeTBXUCURE
Stocks39.4%67.1%
Cash & short-term funds57.2%34.5%
DO3.5%13.3%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)

Country mix

CountryTBXUCURE
US93.1%114.9%
NL7.0%—

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)

Check another pair

FAQ

How much do TBXU and CURE overlap?
About 40% by weight. 8 securities appear in both funds' top 25 holdings; they make up 84.1% of TBXU's assets and 42.4% of CURE's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do TBXU and CURE have in common?
The largest shared holdings are Dreyfus, Goldman Financial, Goldman Sachs Liq Es Fd A, Amgen Inc, Gilead Sciences Inc.
Should I own both TBXU and CURE?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, TBXU or CURE?
CURE is broader, with 67 positions versus 10 for TBXU. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.